Previous Article | Next Article ![]()
Infection and Immunity, January 1999, p. 423-425, Vol. 67, No. 1
Department of Immunology, Max Planck
Institute for Infection Biology, 10117 Berlin,
Germany,1 and
Institute of Tropical
Dermatology and Venereology Alfredo da Matta, 69062 Manaus,
Brazil2
Received 22 July 1998/Returned for modification 26 August
1998/Accepted 29 October 1998
Serum levels of soluble tumor necrosis factor alpha receptor I
(sTNF-RI) were elevated in patients with lepromatous (LL)
reactional-state type II leprosy, and sTNF-RII levels were increased in
patients with full tuberculoid (TT) or LL type II leprosy. The sTNF-R
in sera from patients with type II leprosy, but not other forms of leprosy, inhibited recombinant TNF cytolytic activities in vitro. This
suggests that sTNF-R regulatory activities are partially impaired in
patients with leprosy.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Soluble Tumor Necrosis Factor Alpha Receptors in
Sera from Leprosy Patients
*
Corresponding author. Mailing address:
Max-Planck-Institute for Infection Biology, Monbijoustr. 2, 10117 Berlin, Germany. Phone: 49-30-2802 6587. Fax: 49-30-2802 6212. E-mail:
munk{at}mpiib-berlin.mpg.de.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»